ENHT yields 2000000.00% · MRK yields 2.76%● Live data
📍 ENHT pulled ahead of the other in Year 1
Combined, ENHT + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ENHT + MRK for your $10,000?
enherent Corp. operates as an information technology (IT) services company in the northeastern United States. The company offers IT consultative resource and staffing services to augment client resource demands in the areas of project management, business analysis, systems architecture and design, database architecture and design, application code development, network engineering, and quality assurance and testing. Its application development services comprise planning, design, application code development, testing, and deployment of enhancements to existing systems or new custom application development; and evaluation and implementation of third party business application software. The company's network and security services include planning, architecture, design, and engineering to support the build out, optimization, and security audits of the network infrastructure, as well as implementation of software product licenses or computer equipment. It also provides systems integration services, such as conducting application, data, and technical assessments to determining gaps in the existing environment; making recommendations to address the gaps by leveraging existing IT assets; deploying a combination of application code development, software product implementation, and computer equipment; and integrating new capabilities into the environment to address the gaps. In addition, the company offers advanced analytics that leverages text analytics technology to understand and process free-form text. It serves insurance, financial services, banking and capital markets, retail distribution, apparel, health care, pharmaceutical, and consumer goods industries. The company is headquartered in Syosset, New York.
Full ENHT Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.